NCT00418873 Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward Status TERMINATED Phase PHASE4
NCT00418171 Large Simple Trial (LST) Of Cardiovascular Safety Of Ziprasidone And Olanzapine- (Zodiac) Status COMPLETED Phase PHASE4
NCT00412620 An Evaluation of the Safety and Efficacy of ABT-925 in Subjects With Acute Exacerbation of Schizophrenia Status TERMINATED Phase PHASE2
NCT00411866 Effects Of The Drug Ketoconazole On How The Body Handles The Drug SB773812 Status COMPLETED Phase PHASE1
NCT00409201 Reboxetine Adjuvant Therapy for the Treatment of Schizophrenia Status UNKNOWN Phase PHASE1
NCT00407277 Neural Inhibition as a Mechanism of Nicotine Dependence Among Persons With Schizophrenia Status COMPLETED Phase NA
NCT00406718 Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia Status COMPLETED Phase NA
NCT00406315 Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone Status COMPLETED Phase PHASE4
NCT00404573 Study Evaluating RGH-188 in the Treatment of Patients With Schizophrenia Status COMPLETED Phase PHASE2
NCT00403546 High-Dose Oral Ziprasidone Versus Conventional Dosing in Participants With Residual Schizophrenia Symptoms Status COMPLETED Phase PHASE3
NCT00403247 Effect of High-Dose B-Complex Vitamins on the Symptoms of Schizophrenia Status COMPLETED Phase NA
NCT00401973 Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine Status COMPLETED Phase PHASE3
NCT00401089 Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in Schizophrenia Status COMPLETED Phase PHASE1/PHASE2
NCT00400166 Recovery Guide Intervention for Recurrent Psychiatric Hospitalization Status COMPLETED Phase NA
NCT00399334 PROFILe3: Epidemiologic Survey in Patients With Schizophrenia or Schizoaffective Disorders Status COMPLETED Phase N/A
NCT00396643 Indicated Prevention With Omega-3 Fatty Acids in Adolescents With 'At-Risk-Mental-State' for Psychosis Status COMPLETED Phase PHASE4
NCT00396565 A Study to Evaluate Effectiveness and Safety of ER OROS Paliperidone in Patients With Schizophrenia Status COMPLETED Phase PHASE3
NCT00396214 Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients Status TERMINATED Phase PHASE3
NCT00395915 Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of Schizophrenia Status UNKNOWN Phase PHASE4
NCT00395031 Effect of Ziprasidone on Glucose & Plasma Lipids in Diabetes (II) and Schizophrenia or Schizoaffective Disorder Status COMPLETED Phase PHASE2/PHASE3